Elaine brings more than 25 years of leadership experience in creating and implementing sustainable development, safety, health, and environmental strategy and programs in the mining, chemical, and engineering consulting sectors. She is a non-executive director of Kenmare Resources plc, Great Lakes Dredge and Dock, Sibanye Stillwater, and NovaGold, and is on the Board of  environmental economics non-profit Resources for the Future. In 2020, she retired from Newmont Mining Corporation as the Executive Vice President of Sustainability and External Relations. Prior to Newmont, she served as managing Director of Richards Bay Minerals in South Africa, and Global Head of Health, Safety and Environment at Rio Tinto. She earned her Ph.D. in Analytical Chemistry from Colorado State University.

Miranda is the founding CEO of Renewable Energy Buyers Alliance (REBA), an alliance of large clean energy buyers, developers, and service providers. Previously, she was CEO of Constant Power, Inc. and served as Managing Director of the Rocky Mountain Institute’s Business Renewables Center (RMI), a member-based platform that accelerates corporate purchasing of renewable energy. RMI is the only think-tank exclusively focused on advanced energy’s role in national security, economic prosperity, and solving climate change: topics to which Miranda has devoted her career. From 2014-2017 she served President Obama as the 4th Assistant Secretary of the Air Force for Installations, Environment, & Energy. She received her BS in Psychology from Colorado State University and an MBA from George Washington University.

Leslie is the CEO of Panacea Life Sciences Inc. (PLS), a cannabinoid product company that manufactures and develops medically relevant, THC-free CBD products for humans and pets. She is the founder and former President and CEO of Quintel-MC Incorporated, (Quintel) a business consulting firm, and continues to serve on the board. Previously, Leslie was the Global Practice Leader for Arthur D. Little’s utilities management consulting practice, President of Electronic Data Systems’ (EDS) Utilities, Energy and Chemical divisions, and served as a Vice President with Stone & Webster. She is also a board member or jobZology, a CSU spinoff company which provides a service for modeling best-fit careers through online tools, and test assessments. She earned her BS in Statistics from Colorado State University and her MS in Industrial Engineering and Finance from Iowa State University.

Bruce retired in May 2020 as COO of Arrowhead Pharmaceuticals, Inc. after a more than 30-year career in biotechnology and pharmaceutical research, development, and sales and marketing. Previously he served as CEO of Leonardo Biosystems, Inc. and CEO, member of the Board of Directors of Encysive Pharmaceuticals and Chairman of the Board of Directors of ICON, plc. He also held senior operational roles at Johnson & Johnson, Ortho-Clinical Diagnostics, and Janssen Pharmaceutica (US). Prior to entering the pharmaceutical industry, he was on the medical faculty at the University of Chicago. Bruce received his BS in Physical Sciences from Colorado State University, his MD with Honors from the University of Chicago and was a Fellow at Harvard University.

Kazem is President and CEO of Amarex Clinical Research, a globally active clinical research organization. He co-founded Amarex in 1998 which became part of NSF International in 2019. He also serves as an adjunct professor of biostatistics and epidemiology at George Washington University’s School of Medicine. Kazem began his career as a mathematical statistician working at the Genetics Institute. He has worked in various therapeutic areas in multiple capacities, including as a presenter to the Food and Drug Administration, as an FDA reviewer, and as a sponsor representative in diverse areas including anti-infective drugs, AIDS, cardiovascular diseases, vaccines, and wound healing. Kazem’s expertise has earned him multiple recognition awards from the FDA for his contributions to the drug approval process, particularly for his work on HIV and AIDS clinical trial designs and analyses. He received his MS and Ph.D. in Statistics from Colorado State University.

E. William is currently the CEO at LCY Bioscience and has over 40 years of experience in the biotechnology industry. Prior to founding LCY Bioscience, he was the President and CEO of Verdezyne a synthetic biology company and President and CEO of High Throughput Genomics, Inc., a provider of novel array-based gene expression assay technology for the life science industry. Previously, Dr. Radany was President of Biacore, a spin off from Pharmacia and founder and CEO of NeoGenex. Dr. Radany has held executive positions at Xencor, Caliper Technologies and Stratagene, where he helped establish business relationships with major pharmaceutical and biotechnology companies. Dr. Radany has spoken at numerous conferences and has invented several patents over the past 40 years. Dr. Radany received his Bachelor of Science degree in Cell Biology from Colorado State University and a Ph.D. in Biochemistry /Physiology from the University of Wyoming.

Bonnie is Corporate Vice President at Microsoft and Head of 343 Industries.  She  is responsible for defining the vision and leading the Halo franchise. In 2007, she founded 343 Industries, an entertainment studio committed to fostering the growth and expansion of the Halo franchise, as well as driving innovation across Microsoft platforms. She is passionate about bringing together art and technology to transform how people experience entertainment. Bonnie is also deeply involved in promoting efforts to drive diversity across the games industry and generating interest among women and children in the pursuit of science, technology, engineering and math (STEM) careers. She was named the 2019 inductee of the Academy of Interactive Arts & Sciences Hall of Fame, and has been named one of Fortune’s most powerful women in gaming.  She earned her BA in Technical Communication at Colorado State University in 1989.

Denise is Senior Vice President of 3M’s Corporate Affairs organization. She previously served as Vice President of R&D and Commercialization in 3M’s Industrial Business Group. Before that, Denise was President, 3M Japan LTD, President, Greater China Area, and President of Latin America International Operations for 3M. Denise has held several other leadership positions at 3M, including Vice President and General Manager of 3M’s Aerospace and Aircraft Maintenance division and Managing Director of 3M Belgium. Denise joined 3M in 1989 after completing her Ph.D. in Chemistry at Colorado State University.

Peter I. Wold grew up in Casper, Wyoming and graduated with a B.S. in Biological Science from Colorado State University in 1971. He is currently President of Wold Oil Properties, LLC, an exploration and production company. The company owns and operates wells producing oil and gas in the Rocky Mountain States. Mr. Wold is managing partner of Hole-in-the Wall Ranch, a cattle-ranching operation located at the south end of the Bighorn Mountains near Barnum, Wyoming. He presently serves as Trustee of the Casper Family YMCA, Mountain States Legal Foundation and the Buffalo Bill Center of the West. Mr. Wold was a member of the Wyoming State House of Representatives (1989-1992), served two terms (1984-1990) on the Executive Committee of the Petroleum Association of Wyoming and presently serves as a Director. He also served as Director of Pacificorp, Inc., an electrical and telecommunications utility company (1993-1999); was Director of National Advisory Board to the College of Engineering at the University of Wyoming (1997-2000); member of New York Board of Oppenheimer Funds, Inc., a mutual fund company (2002-2015); served as Commissioner and Chairman of the Wyoming Enhanced Oil Recovery Institute (2003-2012) and on the Board of Arch Coal Company, Inc. (2010-2017).